Investment case
Large-diameter compound-semiconductor integration could lower the cost of photonics and sensing devices. The commercial test is whether development partnerships progress into qualified, repeat production purchases.
PEP RESEARCHSign in with X
13 timeline updates10 relationshipsLatest source
Develops compound-semiconductor materials and devices using large-diameter substrates for photonics and electronics.

Wafer cassette shown on Aeluma’s official website. No specific manufacturing facility is attributed.
Large-diameter compound-semiconductor integration could lower the cost of photonics and sensing devices. The commercial test is whether development partnerships progress into qualified, repeat production purchases.
Materials yield, manufacturing scale and customer qualification remain difficult. Small current revenues, losses and funding requirements can make dilution and execution risk significant.
Measured device performance, customer qualification and evidence that development programs progress toward repeat commercial production.
For fiscal Q1 ended 30 September 2026, revenue was $0.568m, primarily R&D contracts, versus $1.385m a year earlier. Net loss was $3.8m, adjusted EBITDA loss $2.7m and cash $53.9m.…
Aeluma develops short-wave infrared sensing technology using compound semiconductors on larger-diameter silicon substrates.
Markets & applicationsIts materials platform targets lower-cost integration and scaling of compound-semiconductor devices; commercial development remains in progress.
Markets & applicationsThe current investment case appears above. Future saved changes to the publisher thesis or risks retain their previous wording here. Earlier versions have not been reconstructed.
−2.4% vs Q4 FY2026
-59% year over year+14.72 pp vs Q4 FY2026
Reported gross profit / revenue−0.123 USD m vs Q4 FY2026
Standalone quarter−2.13 USD m vs Q4 FY2026
Balance at period endUSD millions, except percentages. Changes compare reported figures and may reflect changes in reporting scope.
Standalone fiscal quarters. Gross margins and growth rates are calculated from the financial tables. Q2–Q4 operating cash flows are derived from comparable cumulative statements. Restricted cash was not separately verified.
Reported quarters, oldest to newest. — means unavailable. Missing observations are not estimated.
Scroll horizontally to compare the reported quarters.
| Metric | Q1 FY2027Ended 30 Sept 2026Reported 12 Nov 2026 | Q4 FY2026Ended 30 Jun 2026Reported 16 Sept 2026 | Q3 FY2026Ended 31 Mar 2026Reported 13 May 2026 | Q2 FY2026Ended 31 Dec 2025Reported 11 Feb 2026 |
|---|---|---|---|---|
| Revenue | 0.568 | 0.582 | 1.222 | 1.272 |
| Revenue growth · YoY | -59% | -55.8% | -2.6% | -21.1% |
| Gross margin | 40.3% | 25.6% | 31.6% | 27.8% |
| Operating cash flow · quarter | -1.746 | -1.623 | -0.577 | -0.251 |
| Cash & equivalents | 53.875 | 56.006 | 37.78 | 38.572 |
| Restricted cash | — | — | — | — |
| Financial debt | 0 | 0 | 0 | 0 |
Figures are rounded. Debt, restricted cash and lease classifications retain the issuer’s stated basis. Sources and calculations are available below.
Calculated gross margin rose to 40.3% in Q1 FY2027 from 25.6% in Q4; adjusted EBITDA loss narrowed from USD2.938m to USD2.742m.
Source · 12 Nov 2026Revenue fell 2.4% sequentially and 59.0% YoY; operating cash outflow was USD1.746m versus derived USD1.623m in Q4.
Source · 12 Nov 2026Customer negotiations and proposed CHIPS funds still require definitive agreements.
Source · 12 Nov 2026No officially confirmed upcoming earnings date is recorded.
View financial calendarLoading Aeluma chart…
Signed agreements and qualified production progress; CHIPS funding remains subject to definitive negotiations.
CEO and CFO available for one-on-one meetings in New York.
The announced window has passed. Completion has not been confirmed in this record.
CEO and CFO available for one-on-one meetings in New York.
The announced window has passed. Completion has not been confirmed in this record.
Issuer calendar confirmed date; displayed PDT timezone appears seasonally inconsistent, omit time.
The announced window has passed. Completion has not been confirmed in this record.
Results published
Results published. See the issuer release for the reported figures, guidance and commercial developments.
Aeluma’s official financial results page organizes fiscal-year and quarterly disclosures with links to Form 10-K and Form 10-Q documents. Its fiscal year ends in June, making the period labels useful when comparing Aeluma with calendar-year companies.
Aeluma reports no volume production of any product offering. Established InGaAs suppliers and alternative photonic materials remain competitors; larger wafers support a potential cost advantage, not demonstrated dominance.
Aeluma’s press release archive provides dated company announcements covering financial results, research awards, manufacturing partnerships and management changes. It is the primary ongoing source for following the company’s transition from development programs toward commercialization.
Market cap. Provider-rounded equity market-cap snapshot, not a live quote or enterprise value.
Institutions. Count covers Fintel's separately reported 13F institutions, excluding NPORT funds. This undated webpage was checked on September 23, 2026; underlying filings are delayed. The broader institutional ownership percentage is omitted because its coverage differs from this count.
Selected major institutional, private-investor and insider positions. The CEO's direct and trust shares are combined once. Dates differ and percentages are provider-reported, except that no unsupported percentage is assigned to the Form 4 position.
| Shareholder / investor | Ownership | Reported holding |
|---|---|---|
Jonathan KlamkinFounder / insiderHolding detailsSum of 1,326,995 common shares indirectly held by the family trust and 2,403 directly held after the reported transactions. Options/RSUs are excluded. No percentage is calculated from a mismatched share-count date. | Not disclosed1,329,398 shares | |
Boisei Investments LLCDisclosed investorHolding detailsProvider lists this entity as 'boisei investments ll'; position date is March 31, 2026. The reported percentage may use a more recent outstanding-share denominator. | 5.19%1,000,000 shares | |
BlackRock, Inc.InstitutionHolding detailsInstitution-level position and percentage as reported by Investing.com. Reporting dates vary from the observation date; percentages may use the provider's current share denominator. Underlying mutual funds are not listed again. | 5.05%973,235 shares | |
D. E. Shaw & Co., L.P.InstitutionHolding detailsInstitution-level position and percentage as reported by Investing.com. Reporting dates vary from the observation date; percentages may use the provider's current share denominator. Underlying mutual funds are not listed again. | 4.14%797,983 shares | |
Vanguard Capital Management, LLCInstitutionHolding detailsInstitution-level position and percentage as reported by Investing.com. Reporting dates vary from the observation date; percentages may use the provider's current share denominator. Underlying mutual funds are not listed again. | 3.42%658,592 shares |
Market caps are dated snapshots checked during publisher-requested reviews. Unavailable sources retain their previous dates; values older than seven days are flagged. Holdings follow the dates of filings or company disclosures and may have changed.
Publicly documented customers, suppliers and collaborations. Status labels distinguish commercial relationships, announced plans and historical references. Some names remain undisclosed; a source date alone does not establish that a relationship continues.
Showing 8 of 10 relationship records · newest publication first
One organisation may appear in several records covering different announcements or roles.
Aeluma’s FY2026 filing names the State University of New York among customers associated with newly awarded government contracts. This supports a funded-development relationship during the fiscal year, without identifying a commercial volume order or a contract-specific amount.
Aeluma executed a wafer development and production agreement using Sumitomo’s existing MOCVD capabilities in Phoenix. The arrangement supports AI datacom photonics and provides a route for future capacity expansion.
Aeluma identifies Tower as a supply-chain partner for scaling wafer production and fabrication in its quantum materials and laser programs. The release documents the manufacturing collaboration without specifying contracted production volumes.
Aeluma announced a U.S. Navy contract supporting compact visible and shortwave-infrared imaging sensors for next-generation submarine systems. The contract is a funded development relationship; the release does not establish production-system delivery.
Aeluma announced a NASA contract to advance entangled photon sources using nonlinear optical materials on 200mm silicon. The customer relationship covers funded research and development, with commercialization and system deployment remaining future goals.
Aeluma and Thorlabs demonstrated integration of aluminum gallium arsenide nonlinear optical material on standard 200mm silicon substrates. The work establishes a technical collaboration aimed at scalable quantum photonic circuits.
Aeluma joined AIM Photonics as a full industry member after collaborating on a government-directed project. The work targets monolithic quantum dot laser integration with AIM photonics capabilities; membership does not establish customer relationships with other members.
Awarded the M-STUDIO development contract announced in September 2024.
Announcement dates, newest first. Plans and targets remain subject to the conditions described in each source.
Showing 12 of 13 updates
For fiscal Q1 ended 30 September 2026, revenue was $0.568m, primarily R&D contracts, versus $1.385m a year earlier. Net loss was $3.8m, adjusted EBITDA loss $2.7m and cash $53.9m. Aeluma advanced high-speed photodetectors and quantum dot lasers with supply-chain partners including Sumitomo Chemical Advanced Technologies. Management reported expanded discussions over potential product opportunities and development investments; several initiatives target potentially high-volume demand for the 2028–2032 AI infrastructure buildout. These are discussions, not disclosed volume orders. Up to $30m proposed CHIPS funding remains subject to diligence and definitive negotiations. The release reiterates the previously covered AIXTRON 200mm-capable equipment purchase; do not duplicate that announcement as a new standalone order.
Aeluma executed an agreement to purchase an AIXTRON G10-AsP MOCVD system configured for its proprietary non-InP photonics processes. The tool supports 150 mm and 200 mm wafers on GaAs and silicon, expanding development and manufacturing capability for photodetectors, quantum-dot lasers and related AI interconnect devices. The announcement builds on several years of collaboration. It confirms an equipment purchase agreement, not completed installation, a disclosed capacity figure or a new end-customer order; price and delivery timing were not disclosed. Aeluma’s fiscal Q1 FY2027 results remain scheduled after the US close on 12 November.
Aeluma will publish results after US market close on 12 November. The call starts at 17:00 EST / 23:00 Berlin. The official announcement replaces the earlier estimated date.
CEO Jonathan Klamkin and CFO Christopher Stewart will attend Craig-Hallum Alpha Select in New York on 17 November and ROTH Technology on 18 November for individual investor meetings. No operating results or customer contracts were announced.
Aeluma appointed former Transphorm co-founder and Renesas GaN division leader Primit Parikh to advise management on strategy and execution, including AI datacom commercialization. His prior employers are biographical references, not newly announced customers or partners. The appointment does not establish a production order, completed qualification or exclusive supply position.
For the fiscal year ended June 30, 2026, Aeluma reported $4.5 million revenue, primarily government R&D, a $9.2 million net loss and $56.0 million cash. Q4 revenue was $0.6 million. The release states $20.1 million net ATM equity proceeds and six signed research contracts totaling $5.3 million; neither is annual product revenue. The up-to-$30 million CHIPS LOI still required definitive negotiations, while prospective AI-datacom NRE agreements remained under discussion.
Aeluma announced an executed agreement with Sumitomo Chemical Advanced Technologies to accelerate photonics wafer development and production for AI datacom. The collaboration supports qualification and manufacturing preparation as Aeluma works toward commercial products.
Aeluma signed a letter of intent for up to USD 30 million of proposed CHIPS funding to advance its non-InP substrate technology for AI datacom. The proposal remains subject to definitive agreement negotiations; the announcement does not mean the full funding was awarded or received.
Aeluma announced more than USD 4 million in government contracts for quantum dot lasers and nonlinear photonic materials. The release also confirms wafer-production and fabrication work with Tower and Sumitomo, supporting development and scaling of its heterogeneous integration platform.
Aeluma and Thorlabs announced work on large-diameter AlGaAs technology for quantum photonics.
Aeluma joined AIM Photonics as a full industry member, supporting work on integrating compound semiconductors with large-diameter silicon platforms.
Aeluma announced a $11.717 million DARPA contract for heterogeneous integration under M-STUDIO, working with Teledyne Scientific and UC Santa Barbara. Funding supports development milestones; the award is not equivalent to immediately recognised revenue.
Source-backed statements and publisher analysis are identified throughout. Research methodology